Relationship of Frailty with Kidney Function in Adults More Than 60-Years-Old: Effect of Using Different Formulas to Estimate Glomerular Filtration Rate

References

• Lv JC, Zhang LX. Prevalence and disease burden of chronic kidney disease. Adv Exp Med Biol. 2019;1165:3–15. doi:10.1007/978-981-13-8871-2_1
   PubMed Web of Science ®Google Scholar
• Wang L, Xu X, Zhang M, et al. Prevalence of chronic kidney disease in China: results from the sixth China chronic disease and risk factor surveillance. JAMA Intern Med. 2023;183(4):298–310. doi:10.1001/jamainternmed.2022.6817
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822. doi:10.1016/S0140-6736(12)60033-6
   PubMed Web of Science ®Google Scholar
• Yamada S, Inaba M. Potassium metabolism and management in patients with CKD. Nutrients. 2021;13(6):1751. doi:10.3390/nu13061751
   PubMed Web of Science ®Google Scholar
• Chen TK, Knicely DH, Grams ME. Chronic kidney disease diagnosis and management: a review. JAMA. 2019;322(13):1294–1304. doi:10.1001/jama.2019.14745
   PubMed Web of Science ®Google Scholar
• Huang X, Jiang X, Wang L, et al. Serum cystatin C and arterial stiffness in middle-aged and elderly adults without chronic kidney disease: a population-based study. Med Sci Monit. 2019;25:9207–9215. doi:10.12659/MSM.916630
   PubMed Web of Science ®Google Scholar
• Seronie-Vivien S, Delanaye P, Pieroni L, et al. Cystatin C: current position and future prospects. Clin Chem Lab Med. 2008;46(12):1664–1686. doi:10.1515/CCLM.2008.336
   PubMed Web of Science ®Google Scholar
• Gao J, Wang Y, Xu J, Jiang J, Yang S, Xiao Q. Life expectancy among older adults with or without frailty in China: multistate modelling of a national longitudinal cohort study. BMC Med. 2023;21(1):101. doi:10.1186/s12916-023-02825-7
   PubMed Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults: evidence for a phenotype. J Gerontol a Biol Sci Med Sci. 2001;56(3):M146–56. doi:10.1093/gerona/56.3.m146
   PubMed Web of Science ®Google Scholar
• Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–2646. doi:10.1016/S0140-6736(19)31138-9
   PubMed Web of Science ®Google Scholar
• Modig S, Lannering C, Ostgren CJ, Molstad S, Midlov P. The assessment of renal function in relation to the use of drugs in elderly in nursing homes; a cohort study. BMC Geriatr. 2011;11:1. doi:10.1186/1471-2318-11-1
   PubMed Web of Science ®Google Scholar
• Gomez C, Vega-Quiroga S, Bermejo-Pareja F, Medrano MJ, Louis ED, Benito-Leon J. Polypharmacy in the elderly: a marker of increased risk of mortality in a population-based prospective study (NEDICES). Gerontology. 2015;61(4):301–309. doi:10.1159/000365328
   PubMed Web of Science ®Google Scholar
• Schaeffner ES, Ebert N, Delanaye P, et al. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med. 2012;157(7):471–481. doi:10.7326/0003-4819-157-7-201210020-00003
   PubMed Web of Science ®Google Scholar
• Fan L, Levey AS, Gudnason V, et al. Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals. J Am Soc Nephrol. 2015;26(8):1982–1989. doi:10.1681/ASN.2014060607
   PubMed Web of Science ®Google Scholar
• Zhu Y, Ye X, Zhu B, et al. Comparisons between the 2012 new CKD-EPI (chronic kidney disease epidemiology collaboration) equations and other four approved equations. PLoS One. 2014;9(1):e84688. doi:10.1371/journal.pone.0084688
   PubMed Web of Science ®Google Scholar
• Shlipak MG, Matsushita K, Arnlov J, et al. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med. 2013;369(10):932–943. doi:10.1056/NEJMoa1214234
   PubMed Web of Science ®Google Scholar
• Ebert N, Shlipak MG. Cystatin C is ready for clinical use. Curr Opin Nephrol Hypertens. 2020;29(6):591–598. doi:10.1097/MNH.0000000000000638
   PubMed Web of Science ®Google Scholar
• Inker LA, Schmid CH, Tighiouart H, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367(1):20–29. doi:10.1056/NEJMoa1114248
   PubMed Web of Science ®Google Scholar
• Hemmelgarn BR, Zhang J, Manns BJ, et al. Progression of kidney dysfunction in the community-dwelling elderly. Kidney Int. 2006;69(12):2155–2161. doi:10.1038/sj.ki.5000270
   PubMed Web of Science ®Google Scholar
• Walker SR, Gill K, Macdonald K, et al. Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol. 2013;14:228. doi:10.1186/1471-2369-14-228
   PubMed Web of Science ®Google Scholar
• Denic A, Glassock RJ, Rule AD. Structural and functional changes with the aging kidney. Adv Chronic Kidney Dis. 2016;23(1):19–28. doi:10.1053/j.ackd.2015.08.004
   PubMed Web of Science ®Google Scholar
• Lin JX, Huang YQ, Xie JW, et al. Age-adjusted Charlson Comorbidity Index (ACCI) is a significant factor for predicting survival after radical gastrectomy in patients with gastric cancer. BMC Surg. 2019;19(1):53. doi:10.1186/s12893-019-0513-9
   PubMed Web of Science ®Google Scholar
• Peralta CA, Shlipak MG, Judd S, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA. 2011;305(15):1545–1552. doi:10.1001/jama.2011.468
   PubMed Web of Science ®Google Scholar
• Stevens PE, Levin A; Kidney Disease: Improving Global Outcomes Chronic Kidney Disease Guideline Development Work Group M. Evaluation and management of chronic kidney disease: synopsis of the kidney disease: improving global outcomes 2012 clinical practice guideline. Ann Intern Med. 2013;158(11):825–830. doi:10.7326/0003-4819-158-11-201306040-00007
   PubMed Web of Science ®Google Scholar
• Onopiuk A, Tokarzewicz A, Gorodkiewicz E. Cystatin C: a kidney function biomarker. Adv Clin Chem. 2015;68:57–69. doi:10.1016/bs.acc.2014.11.007
   PubMed Web of Science ®Google Scholar
• Zhang C, Wang J, Xie X, Sun D. Low serum vitamin D concentration is correlated with anemia, microinflammation, and oxidative stress in patients with peritoneal dialysis. J Transl Med. 2021;19(1):411. doi:10.1186/s12967-021-03077-w
   PubMed Web of Science ®Google Scholar
• Ballew SH, Chen Y, Daya NR, et al. Frailty, kidney function, and polypharmacy: the atherosclerosis risk in communities (ARIC) Study. Am J Kidney Dis. 2017;69(2):228–236. doi:10.1053/j.ajkd.2016.08.034
   PubMed Web of Science ®Google Scholar
• Inoue T, Shinjo T, Matsuoka M, et al. The association between frailty and chronic kidney disease; cross-sectional analysis of the Nambu Cohort Study. Clin Exp Nephrol. 2021;25(12):1311–1318. doi:10.1007/s10157-021-02110-y
   PubMed Web of Science ®Google Scholar
• Wilhelm-Leen ER, Hall YN, Tamura MK, Chertow GM. Frailty and chronic kidney disease: the third national health and nutrition evaluation survey. Am J Med. 2009;122(7):664–71 e2. doi:10.1016/j.amjmed.2009.01.026
   PubMed Web of Science ®Google Scholar
• Hoogendijk EO, Afilalo J, Ensrud KE, Kowal P, Onder G, Fried LP. Frailty: implications for clinical practice and public health. Lancet. 2019;394(10206):1365–1375. doi:10.1016/S0140-6736(19)31786-6
   PubMed Web of Science ®Google Scholar
• Hanlon P, Nicholl BI, Jani BD, Lee D, McQueenie R, Mair FS. Frailty and pre-frailty in middle-aged and older adults and its association with multimorbidity and mortality: a prospective analysis of 493 737 UK Biobank participants. Lancet Public Health. 2018;3(7):e323–e332. doi:10.1016/S2468-2667(18)30091-4
   PubMed Web of Science ®Google Scholar
• Vetrano DL, Palmer K, Marengoni A, et al. Frailty and multimorbidity: a systematic review and meta-analysis. J Gerontol a Biol Sci Med Sci. 2019;74(5):659–666. doi:10.1093/gerona/gly110
   PubMed Web of Science ®Google Scholar
• Drost D, Kalf A, Vogtlander N, van Munster BC. High prevalence of frailty in end-stage renal disease. Int Urol Nephrol. 2016;48(8):1357–1362. doi:10.1007/s11255-016-1306-z
   PubMed Web of Science ®Google Scholar
• Wang M, Sun X, Zhang W, et al. Frailty and the risk of kidney function decline in the elderly population: the rugao longevity and ageing study. Nephrol Dial Transplant. 2021;36(12):2274–2281. doi:10.1093/ndt/gfaa323
   PubMed Web of Science ®Google Scholar
• Bolignano D, Mattace-Raso F, Sijbrands EJ, Zoccali C. The aging kidney revisited: a systematic review. Ageing Res Rev. 2014;14:65–80. doi:10.1016/j.arr.2014.02.003
   PubMed Web of Science ®Google Scholar
• Howlett SE, Rockwood K. New horizons in frailty: ageing and the deficit-scaling problem. Age Ageing. 2013;42(4):416–423. doi:10.1093/ageing/aft059
   PubMed Web of Science ®Google Scholar